Literature DB >> 6112660

Homogeneity of beta 2-adrenoceptors on rat erythrocytes and reticulocytes. A comparison with heterogeneous rat lung beta-adrenoceptors.

K Dickinson, A Richardson, S R Nahorski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6112660

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  7 in total

1.  Distribution of beta 1- and beta 2-adrenoceptors in mouse trachea and lung: a quantitative autoradiographic study.

Authors:  P J Henry; P J Rigby; R G Goldie
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

2.  Autoradiographic localization of beta-adrenoceptor subtypes in guinea-pig kidney.

Authors:  R Lew; R J Summers
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

3.  Autoradiographic analysis of the distribution of beta-adrenoceptors in the dog splenic vasculature.

Authors:  S Lipe; R J Summers
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

4.  Direct labelling of myocardial beta 1-adrenoceptors. Comparison of binding affinity of 3H-(-)-bisoprolol with its blocking potency.

Authors:  A J Kaumann; H Lemoine
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

5.  Irreversible blockade of beta-adrenergic receptors with a bromoacetyl derivative of pindolol.

Authors:  V Homburger; H Gozlan; R Bouhelal; M Lucas; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

6.  Characterization of rat liver beta-adrenoceptors during perinatal development as determined by [125I]-iodopindolol radioligand binding assays.

Authors:  K Snell; C A Evans
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

7.  Beta-adrenoceptor heterogeneity in guinea-pig airways: comparison of functional and receptor labelling studies.

Authors:  H Carswell; S R Nahorski
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.